Then, we hypothesize that CRB2 gene might be a crucial candidate modifier for the severity of CRB1-associated retinopathies, and moderate levels of CRB2 could partially protect against the degeneration caused by CRB1 deficiency. This evidence concerns the gene CRB2 and retinal disorder.